Net Income

The bakery chain saw gross profit climb 14.2%, but a staggering 99% EPS drop and struggling U.S. stores paint a complex picture for investors.

SiMa.ai's Modalix SoM wins a major industry award, signaling a shift in the edge AI market toward power-efficient, on-device generative AI.

SJCAM's new SJ30 challenges the action cam market with 8K video, a unique dual-lens system for low light, and a focus on everyday creators.

A Minnesota man who lost his leg due to a faulty Jeep gear shifter, a defect also linked to actor Anton Yelchin's death, has won a landmark $18M verdict.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

UAB Kvartalas completes its flagship office project but reports €3.5M in losses, calling a critical meeting as a €40.6M bond payment deadline nears.

As cyber threats loom, Rpharmy's SOC 2 Type II audit signals a deep commitment to protecting sensitive patient data and ensuring system reliability.

As pay transparency and economic pressures mount, a new unified platform aims to democratize compensation intelligence across the entire organization.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

Developer Cole West announces Lone Tree, a 38-home community in Syracuse, answering high demand with homes from the $700Ks and a unique focus on local history.

Two Touchstone funds earned prestigious LSEG Lipper Awards for a decade of consistent, risk-adjusted returns, validating their active management strategy.

A new partnership will embed sensors in spinal implants, aiming to solve high patient dissatisfaction rates and disrupt a multi-billion dollar market.

Xen Sams' 'A Moment of Xen' expands beyond radio, building a media empire with partners like Taylor Sheridan's Bosque Ranch and a unique ecosystem model.

Fairbridge Asset Management’s John Lettera to address family offices as non-bank lenders fill a crucial financing gap in a complex real estate market.

The new Future Mineral UV Defense SPF 50 promises not just protection, but clinically proven anti-aging results and post-procedure care.

A national advocacy group accuses New Mexico's AG of using 'Trump-style' fear tactics in a child welfare report, warning his approach could harm more children.

Upcoming Phase 1 data for ABCL635 could validate a novel antibody approach for hot flashes, challenging the market and offering new hope for millions.

As POSaBIT preps its Q4 earnings call, investors are watching to see if record profits can outweigh falling revenue in the competitive cannabis tech space.